Faro AI Raises $37.3 Million Series B As Platform Reaches 6 Of World’s 10 Largest Pharma Companies
By Amit Chowdhry ● Today at 4:56 PM
Faro AI has raised $37.3 million in Series B funding to expand its agentic AI platform for clinical development, as pharmaceutical companies increasingly turn to artificial intelligence to improve clinical trial design and execution. Merck Global Health Innovation Fund and S32 co-led the financing. Existing investors General Catalyst, Northpond Ventures, Polaris Partners, PTX Capital and Zetta also participated, alongside new investor Ankona Capital.